The results of this study suggest that ZCCHC4 is abnormally highly expressed in various digestive tract tumor tissues and may be a key regulator of CRC progression, and its knockdown can significantly inhibit tumor progression. The gene discussed is ZCCHC4; the disease is neoplasm.